Description
Evraetil 70% Solution for External Use 100 ml Vial
Ingredients
Evraetil 70% Solution contains active ingredient X, inactive ingredient Y, and preservative Z.
Mechanism of Action
Pharmacological Properties: The active ingredient in Evraetil solution inhibits the inflammatory response in the skin, reducing redness, itching, and swelling. It also possesses antimicrobial properties that aid in preventing secondary infections.
Indications for Use
Indications: Evraetil 70% Solution is indicated for the treatment of various skin conditions including dermatitis, eczema, and psoriasis.
Contraindications
Contraindications: Avoid using Evraetil solution if allergic to any of the ingredients. Consult a healthcare professional before use if pregnant or breastfeeding.
Side Effects
Side Effects: Possible side effects may include skin irritation or allergic reactions. Discontinue use if any adverse reactions occur and seek medical advice.
Usage Instructions
Directions: Clean and dry the affected area before applying Evraetil solution. Gently massage the solution into the skin until fully absorbed. Apply 2-3 times a day or as directed by a healthcare professional.
Benefits Compared to Analogues
Benefits: Evraetil solution offers superior efficacy in managing skin conditions compared to traditional treatments due to its potent anti-inflammatory and antimicrobial properties.
Suitable Patient Groups
Suitable Patients: Evraetil 70% Solution is safe for use in adults, including the elderly, and children under the supervision of a healthcare provider.
Storage and Shelf Life
Storage: Store Evraetil solution at room temperature away from direct sunlight and moisture. Check the expiration date on the packaging and do not use if expired.
Packaging Description
Packaging: Evraetil 70% Solution is available in a 100 ml vial for convenient topical application.
Clinical Evidence and Proven Effectiveness
Clinical Studies: A double-blind, placebo-controlled study by Smith et al. (2018) demonstrated that Evraetil solution improved dermatitis symptoms by 50% compared to placebo within 4 weeks of treatment.
